SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1719Here's the abstract for that pivotal PII MM study. it doesn't add much tuck-7/17/2003
17187/12/2003, 11:50 AM - 12:15 PM Session «Symposium 4: New Targeted Therapiesmicrocapfun-7/15/2003
1717interesting take from the Motley Fool Biotech's (Latest) Big Bang After yeadavid staton-7/15/2003
1716The multi-tasking Velcade deal By Kathryn Calkins Senior Writer [Some commentsIcebrg-7/13/2003
1715From Briefing this morning re Business Week... * 06:58 ET Millennium Pharma'Ian@SI-7/11/2003
1714My projection (optimistic) is $6 M for 2Q, and ~$110M for year. I count on off-lMiljenko Zuanic-7/11/2003
1713<i> Is it the actual use of the drug, which should be a relatively good inBiomaven-7/11/2003
1712Velcade mathematics I picked the following from Yahoo (msg # 41765), which mighIcebrg-7/11/2003
1711Heres' the FULL PR: Millennium Announces Changes in Senior Management ThurSemiBull-7/10/2003
1710It sound to me that MLNM will get rid of all cardiovascular franchise. At what pMiljenko Zuanic-7/10/2003
1709No comments on Kailian "leaving the company"? He's 58. Might wanmicrocapfun-7/10/2003
1708From Briefing this morning... * 08:06 ET Piper Jaffray initiates coverage on seIan@SI-7/8/2003
1707Reopro <i> Message #1692 from tuck at Jul 2, 2003 4:48 PM Full article microcapfun-7/6/2003
1706I am a surgeon. The 10% to 30% who are not insured are getting health care at clPrasanna L Soni-7/4/2003
1705>>Reopro wins Integrillin second Aggrastat third << More or less, btuck-7/3/2003
1704Thanks Tuck. Interesting. Just to save others the time: Reopro wins Integrillkeokalani'nui-7/3/2003
1703Using yeast to probe the mechanism of action of MLN944 (XR5944), a novel bis-pheIcebrg-7/3/2003
1702Comparison of the cellular exposure time of XR5944 (MLN944) and known topoisomerIcebrg-7/3/2003
1701To add to the complexity: In the US people without any medical coverage are treIRWIN JAMES FRANKEL-7/3/2003
1700>>That must mean the Swiss spend about the same as the U.S. on a per persoIcebrg-7/3/2003
1699That must mean the Swiss spend about the same as the U.S. on a per person basis Robohogs-7/3/2003
1698<i> << MLNM retained all commercial rights for Velcade in the US (whIcebrg-7/3/2003
1697Millennium and Xenova Initiate Phase I Clinical Trial Of MLN944 Thursday July 3,Icebrg-7/3/2003
1696Millennium Initiates Phase II Clinical Trial with VELCADE(TM) (Bortezomib) for ISemiBull-7/2/2003
1695Cancer Research 63, 3495-3502, July 1, 2003] © 2003 American Association foMiljenko Zuanic-7/2/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News